Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: Comparison with plasma metanephrines and 123I-MIBG scan

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 50, Issue 4, 2006, Pages 344-347

  Giovanella, Luca ^a   Squin, N ^b   Ghelfo, A ^b   Ceriani, L ^a  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b Department of Pathology   (Italy)

Author keywords

Chromogranin A; Immunoradiometric assay; Metanepherines; Pheochromocytoma; Radionuclide imaging

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BIOLOGICAL MARKER; CHROMOGRANIN A; METADRENALIN;

ABDOMEN; ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTICLE; BLOOD DONOR; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ESSENTIAL HYPERTENSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; HUMAN; IMMUNORADIOMETRIC ASSAY; MALE; PHEOCHROMOCYTOMA; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; WHOLE BODY SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CHROMOGRANIN A; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; METANEPHRINE; MIDDLE AGED; NEOPLASM PROTEINS; PHEOCHROMOCYTOMA; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33846469382     PISSN: 11250135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rosano TG, Swift TA, Hayes LW. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma. Clin Chem 1991;37:1854-67.
2. Witteles RM, Kaplan EL, Roizen MF. Sensitivity of diagnostic and localization tests for pheochromocytoma in clinical practice. Arch Intern Med 2000;160:2521-4.
3. Weissmann C, Jamdar SC, Soo E. Do synthetic adrenergic agents interfere with the measurement of endogenous plasma catecholamine concentration? J Crit Care 1995;10:72-7.
4. Plouin PF, Gimenez-Roqueplo AP, La Batide Alanore A, Salenave S, Duclos JM. Recent progress in the diagnosis, prognostic evaluation and treatment of pheochromocytoma. Rev Med Interne 2000;21:1075-85.
5. Bravo EL. Plasma or urinary metanephrines for the diagnosis of pheochromocytoma? That is the question. Ann Intern Med 1996; 125:331-2.
6. Eisenhofer G, Keiser H, Friberg P, Meyez E, Huynh TT, Hiremagalur B et al. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab 1998;83:2175-85.
7. Sawka AM, Gafni A, Thabane L, Young WF Jr. The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocrinol Metab 2004;89:2859-66.
8. Nobels FRE, Kwekkeboom DJK, Bouillon R, Lamberts SWJ. Chromogranin-A: its clinical value as marker of neuroendocrine tumours. Eur J Clin Invest 1998;28:431-40.
9. Giovanella L, La Rosa S, Ceriani L, Uccella S, Garancini S. Chromogranin A as serum marker of neuroendocrine tumors: comparison with neuron-specific enolase and correlation with immunohistochemical findings. Int J Biol Markers 1999;14: 160-6.
10. Stridsberg M, Husebye ES. Chromogranin A and chromogranin B are sensitive circulating markers for pheochromocytoma. Eur J Endocrinol 1997;136:67-73.
11. Hsiao RJ, Parmer RJ, Takyyuddin MA, O'Connor DT. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine 1991;70:33-45.
12. Mulligan LM, Kwok JBJ, Healey CS. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993;363:458-60.
13. Ramsay LE, Williams B, Johnston GD, McGregor GA, Poston L, Potter JF et al. British Hypertension Society guidelines for hypertension management: summary. BMJ 1999;319:630-5.
14. Degorce F, Goumon Y, Jacquemart L, Vidaud C, Bellanger L, Pons-Anicet D et al. A new human chromogranin A (CgA) immunora-diometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245). Br J Cancer 1999;79:65-71.
15. Lenders JW, Eisenhofer G, Armando I, Keiser HR, Goldstein DS, Kopin IJ. Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem 1993;39:97-103.
16. Singh RJ. Advances in metanephrine testing for diagnosis of pheochromocytoma. Clin Lab Med 2004;24:85-103.
17. Graham PE, Smythe GA, Edwards GA, Lazarus L. Laboratory diagnosis of phaeochromocytoma: which analytes should we measure? Ann Clin Biochem 1993;30(Pt 2):129-34.
18. Peaston RT, Lai LC. Biochemical detection of pheochromocytoma: should we still be measuring urinary HMMA? J Clin Pathol 1993;46:734-7.
19. Hernandez FC, Sanchez M, Alvarez A, Diaz J, Pascual R, Perez M et al. A five-year report on experience in the detection of pheochromocytoma. Clin Biochem 2000;33:649-55.
20. Sawka AM, Prebtani AP, Thabane L, Gafni A, Levine M, Young WF Jr. A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endocr Disord 2004;4:2.
21. Roden M, Raffesberg W, Raber W, Bernroider E, Niederle B, Waldhausl W et al. Quantification of unconjugated metanephrines in human plasma without interference by acetaminophen. Clin Chem 2001;47:1061-7.
22. Raber W, Raffesberg W, Bischof M, Scheuba C, Niederle B, Gasic S et al. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med 2000;160:2957-63.
23. Giovanella L, Ceriani L. Serum chromogranin A immunoradiometric assay in the diagnosis of pheochromocytoma. Int J Biol Markers 2002;17:130-4.
24. 131I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. J Nucl Med 2001;42:993-7.